Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
8 Patents
#638 in San Diego, CA
#8,556 in California
#35,984 in US
Actimis Pharmaceuticals, Inc.
Forward Citations = 8
17 inventors:
San Diego, CA, United States of America
Actimis Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 100.0
CIPO Patents = 3
EPO Patents = 4
Forward Citations = 8
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Tai Wei Ly (5 out of 24 patents)
Takashi Yoshino (3 out of 13 patents)
Kevin Bacon (3 out of 12 patents)
4. Klaus Urbahns (3 out of 24 patents)
5. Takuya Shintani (3 out of 10 patents)
6. Tai-wei Ly (3 out of 3 patents)
7. Hiromi Sugimoto (3 out of 8 patents)
8. Marie Chantal Siu-Ying Tran (2 out of 4 patents)
9. Hiroki Sato (2 out of 7 patents)
10. Kazuho Tanaka (2 out of 2 patents)
11. Yoshihisa Manabe (2 out of 2 patents)
12. Masanori Seki (2 out of 2 patents)
13. Yuji Koriyama (2 out of 12 patents)
14. Hui-Yin Li (1 out of 34 patents)
15. Garrett Thomas Potter (1 out of 12 patents)
8 patents:
6. 7960393 - Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 (2011-06-14),
Company Overview
Actimis Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for respiratory and inflammatory diseases. With a strong pipeline of novel drug candidates and a commitment to advancing healthcare, Actimis is dedicated to improving the lives of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Actimis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/actimis-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]